Labetalol
Back to searchMolecule Structure
Scientific Name
Labetalol
Description of the Drug
Labetalol is an alpha and beta adrenergic antagonist used to treat hypertension, angina, and sympathetic overactivity syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00598
http://www.drugbank.ca/drugs/DB00598
Brand Name(s)
Not Available
Company Owner(s)
Eywa Pharma Inc, Glaxosmithkline, Schering Corp Sub Schering Plough Corp, Watson Laboratories Inc, Zydus Pharmaceuticals Usa Inc, Sebela Ireland Ltd, Akorn Operating Co Llc, Teva Pharmaceuticals Usa Inc, Rubicon Research Private Ltd, Innogenix Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Adrenergic receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL2331074 |
Clinical Trial(s)
Unichem Links
Atlas | labetalol | ||
SureChEMBL | SCHEMBL4582 | ||
PharmGKB | PA164743150 | ||
Human Metabolome Database | HMDB0014736 | ||
DrugBank | DB00598 | ||
PubChem: Thomson Pharma | 14777379 | ||
PubChem | 3869 | ||
Mcule | MCULE-6427232261 | ||
LINCS | LSM-1282 | ||
Nikkaji | J19.703C | ||
BindingDB | 25758 | ||
EPA CompTox Dashboard | DTXSID2023191 | ||
DrugCentral | 1531 | ||
Brenda | 236892 | ||
ChemicalBook | CB7735086 | ||
Guide to Pharmacology | 7207 | ||
rxnorm | LABETALOL HYDROCHLORIDE | TRANDATE | LABETALOL |
KEGG Ligand | C07063 | ||
ChEBI | 167638 |